← Leaderboards
Adele Moatti
North Carolina State University Raleigh
$702,632
Attributed
$702,632
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$702,632 · 2
By mechanism
R00$498,000 · 1
K99$204,632 · 1
Top collaborators
No co-investigators on record.
Most similar at North Carolina State University Raleigh
Same institution · by research overlap
- Ke Cheng$24,298,318
- Phuong-Uyen C Dinh$1,109,329
- Alon Greenbaum$1,825,310
Others in their field
Other Rising Stars on “Genes”
- Mari Ostendorf · University Of Washington$51,931,230
- Suma Babu · Massachusetts General Hospital$28,791,731
- Sabrina Paganoni · Massachusetts General Hospital$28,791,731
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
Research focus
GenesAffectAmino Acid SequenceBiological ModelsCell MembraneAnimal ModelCellsAnimalsClinical TreatmentClinical TrialsCochleaDeafnessDiffuseDisabilityDrug ScreeningEfficacy TestingEncapsulatedExcisionExosomeExtracellularExtracellular VesiclesFamily SuidaeFda ApprovedGene Therapy
Grant awards (4)
Enhanced intratympanic delivery of therapeutics to treat and prevent hearing loss using nanovesicles in the porcine model$249,000
R00 · FY2025 · DC · contact PI
Enhanced intratympanic delivery of therapeutics to treat and prevent hearing loss using nanovesicles in the porcine model$249,000
R00 · FY2024 · DC · contact PI
Enhanced intratympanic delivery of therapeutics to treat and prevent hearing loss using nanovesicles in the porcine model$102,316
K99 · FY2023 · DC · contact PI
Enhanced intratympanic delivery of therapeutics to treat and prevent hearing loss using nanovesicles in the porcine model$102,316
K99 · FY2022 · DC · contact PI